scispace - formally typeset
R

R J Parmer

Researcher at Veterans Health Administration

Publications -  14
Citations -  743

R J Parmer is an academic researcher from Veterans Health Administration. The author has contributed to research in topics: Chromogranin A & Blood pressure. The author has an hindex of 11, co-authored 14 publications receiving 707 citations. Previous affiliations of R J Parmer include United States Department of Veterans Affairs & Vanderbilt University.

Papers
More filters
Journal ArticleDOI

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

TL;DR: This small domain within chromogranin A may contribute to a novel, autocrine, homeostatic (negative-feedback) mechanism controlling catecholamine release from chromaffin cells and neurons.
Journal ArticleDOI

Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.

TL;DR: It is demonstrated that chromogranin A is a substrate for the endogenous endoproteases PC1 and furin in vivo, and that such processing influences its trafficking into the regulated secretory pathway; furthermore, lack of change in chromoganin B and secretogran in II cleavage after diminution of PCl suggests that the action of PC1 on chromog Granin A may be specific within the chromog Cranin/secretogranIn protein family.
Journal ArticleDOI

Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension.

TL;DR: It is concluded that heterogeneous, bimodally distributed hemodynamic and biochemical responses to α2-adrenergic blockade in subjects with positive family histories of hypertension suggest a discrete subgroup with early expression of perhaps Mendian traits associated with hypertension itself may be associated with later phenotypes.
Journal ArticleDOI

Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy.

TL;DR: The role of serotonin as a mediator of emesis associated with cisplatin is supported and it is suggested that plasma CgA level is a valuable tool in studies of chemotherapy-induced emesis.